The CD8+ T cell infiltration mirrored the results seen in the 344SQPD1R and KPPDL1 tumor models, with reduced CD8+ T cell infiltration with ATX overexpression in IgG-treated tumors and a marked reduction in the face of anti–PD-1 (Figure 4C). This evidence concerns the gene CD8A and neoplasm.